ES524150A0 - Un procedimiento de separar un componente de proteina plasmatica de su mezcla en un sistema de cultivo de celulas. - Google Patents

Un procedimiento de separar un componente de proteina plasmatica de su mezcla en un sistema de cultivo de celulas.

Info

Publication number
ES524150A0
ES524150A0 ES524150A ES524150A ES524150A0 ES 524150 A0 ES524150 A0 ES 524150A0 ES 524150 A ES524150 A ES 524150A ES 524150 A ES524150 A ES 524150A ES 524150 A0 ES524150 A0 ES 524150A0
Authority
ES
Spain
Prior art keywords
separating
procedure
mixture
protein component
plasma protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES524150A
Other languages
English (en)
Other versions
ES8500990A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of ES8500990A1 publication Critical patent/ES8500990A1/es
Publication of ES524150A0 publication Critical patent/ES524150A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/848Escherichia
    • Y10S435/849Escherichia coli
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/823Lower fungi, e.g. mold
    • Y10S530/824Yeasts
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/843Digestive system
    • Y10S530/846Liver

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES524150A 1982-07-19 1983-07-15 Un procedimiento de separar un componente de proteina plasmatica de su mezcla en un sistema de cultivo de celulas. Granted ES524150A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/399,604 US4382028A (en) 1982-07-19 1982-07-19 Separation of plasma proteins from cell culture systems

Publications (2)

Publication Number Publication Date
ES8500990A1 ES8500990A1 (es) 1984-11-01
ES524150A0 true ES524150A0 (es) 1984-11-01

Family

ID=23580190

Family Applications (1)

Application Number Title Priority Date Filing Date
ES524150A Granted ES524150A0 (es) 1982-07-19 1983-07-15 Un procedimiento de separar un componente de proteina plasmatica de su mezcla en un sistema de cultivo de celulas.

Country Status (11)

Country Link
US (1) US4382028A (es)
EP (1) EP0099871B1 (es)
JP (1) JPS5928492A (es)
AT (1) ATE24934T1 (es)
AU (1) AU552859B2 (es)
CA (1) CA1202566A (es)
DE (1) DE3369159D1 (es)
ES (1) ES524150A0 (es)
HU (1) HU196832B (es)
IL (1) IL69272A (es)
ZA (1) ZA835181B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4517294A (en) * 1982-03-03 1985-05-14 Genentech, Inc. Human antithrombin III
US4632981A (en) * 1982-07-30 1986-12-30 Genentech, Inc. Human antithrombin III
US4533496A (en) * 1984-05-08 1985-08-06 Monsanto Company Method of isolating monoclonal antibodies from hybridoma cultures
US4554337A (en) * 1985-01-18 1985-11-19 Ralston Purina Company Modified protein adhesive binder and process for producing
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
FR2579224B1 (fr) * 1985-03-25 1987-05-22 Genetica Procede de preparation microbiologique de la serum-albumine humaine
US4780529A (en) * 1985-08-09 1988-10-25 Biotech Research Laboratories, Inc. Isolation of an endotoxin inactivator from human plasma, and methods of use
US4677194A (en) * 1985-08-09 1987-06-30 Biotech Research Laboratories, Inc. Isolation of an endotoxin inactivator from human plasma
US5658790A (en) * 1986-09-04 1997-08-19 Bio 101, Inc. Cell culture media formulated in unit dose
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
EP0482088B1 (en) * 1989-07-20 1999-03-31 Analytical Control Systems, Inc. Improved stable coagulation controls
US5939325A (en) * 1989-07-20 1999-08-17 Analytical Control Systems, Inc. Stable whole blood coagulation controls
WO1991002075A1 (fr) * 1989-07-31 1991-02-21 Institut Belka Akademii Nauk Sssr Procede d'obtention de polypeptides dans un systeme de translation exempt de cellules
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
DE69920711D1 (de) 1998-07-21 2004-11-04 Monsanto Technology Llc Klärung von protein-niederschlagsuspensionen durch verwendung von anionischen polymerischen flockungsmitteln
AUPR638801A0 (en) * 2001-07-13 2001-08-09 Life Therapeutics Limited Factor viii separation
US20060257958A1 (en) * 2005-05-13 2006-11-16 Pronucleotein Biotechnologies, Llc Magnetically-assisted test strip cartridge and method for using same
FR2902799B1 (fr) 2006-06-27 2012-10-26 Millipore Corp Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
WO2008079280A1 (en) 2006-12-21 2008-07-03 Millipore Corporation Purification of proteins
US8569464B2 (en) * 2006-12-21 2013-10-29 Emd Millipore Corporation Purification of proteins
US8362217B2 (en) 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
US8999702B2 (en) * 2008-06-11 2015-04-07 Emd Millipore Corporation Stirred tank bioreactor
US20100190963A1 (en) 2008-12-16 2010-07-29 Millipore Corporation Stirred Tank Reactor And Method
BR112012028977B1 (pt) 2010-05-17 2020-05-05 Emd Millipore Corp método de purificação de biomolécula por meio de polímeros estímulo-responsivos
CN113025684A (zh) * 2019-12-25 2021-06-25 深圳市帝迈生物技术有限公司 活化部分凝血活酶时间检测试剂以及试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3554985A (en) * 1963-01-02 1971-01-12 Monsanto Co Cross-linked copolymer polyelectrolytes based on alpha,beta-ethylenically unsaturated acids
US3555001A (en) * 1969-05-29 1971-01-12 Monsanto Co Process for the fractionation of plasma and serum using water-insoluble polyelectrolytes containing diloweralkylaminoloweralkylimide groups
DD139949A3 (de) * 1974-10-23 1980-01-30 Luebbert Gustav Adolf Verfahren zur abtrennung von mikroorganismen
CA1101332A (fr) * 1976-01-30 1981-05-19 Edward Shanbrom Procedes simplifies pour la preparation de concentres de facteur viii de tres grande purete
NL7708005A (nl) * 1976-07-22 1978-01-24 Monsanto Co Werkwijze voor de bereiding van serumalbumine.
US4081432A (en) * 1977-07-25 1978-03-28 Monsanto Company Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers
ES471858A1 (es) * 1977-07-25 1979-02-01 Monsanto Co Un metodo para separar el factor especifico de coagulacion de la sangre de una mezcla con otras proteinas de la sangre en un medio fluido

Also Published As

Publication number Publication date
IL69272A0 (en) 1983-11-30
ZA835181B (en) 1984-06-27
ES8500990A1 (es) 1984-11-01
ATE24934T1 (de) 1987-01-15
JPH0443638B2 (es) 1992-07-17
EP0099871B1 (en) 1987-01-14
AU1693283A (en) 1984-01-26
US4382028A (en) 1983-05-03
DE3369159D1 (en) 1987-02-19
AU552859B2 (en) 1986-06-26
EP0099871A1 (en) 1984-02-01
JPS5928492A (ja) 1984-02-15
CA1202566A (en) 1986-04-01
IL69272A (en) 1988-02-29
HU196832B (en) 1989-01-30

Similar Documents

Publication Publication Date Title
ES524150A0 (es) Un procedimiento de separar un componente de proteina plasmatica de su mezcla en un sistema de cultivo de celulas.
BR0008772B1 (pt) vetor de expressão, célula bacteriana ou fúngica cultivada, processos para expandir in vitro células hematopoiéticas e progenitores de células hematopoiéticas, e para detectar a presença de rna de ligando zalfa11 e de ligando zalfa 11 in vitro em uma amostra biológica.
DK426386D0 (da) Fremgangsmaade til rensning og aktivering af proteiner fra uoploeselige inklusionslegemer
YU45871B (sh) Polipeptid sa humanim imunointerferonskim (ifn-gama) svojstvima
BG60256B1 (bg) Рекомбинантен метод за получаване на лимфотоксин
EA199700399A1 (ru) Способ крупномасштабной очистки плазмид
IL123641A0 (en) Circular dna molecule with conditional origin of replication method for preparing the same and use thereof in gene therapy
NZ310710A (en) Fermentative production of hydrophobic proteins such as ifn-<beta>
AU5426286A (en) Proteins immobilised on polyamides or cellulose hydrate and the use thereof for the preparation of biocatalysts, test strips or chromatography materials
Misra et al. Lymphocyte plasma membranes II. Cytochemical localization of 5′-nucleotidase in rat lymphocytes
KR900702009A (ko) 인체 a형 모노아민 옥시다제를 코오딩 하는 dna
WO2001042283A3 (en) Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation
Schreurs et al. Chemotropism and branching as alternative responses of Achlya bisexualis to amino acids
Zanders et al. Separation and characterization of a protein antigen from cells of Streptococcus mutans
Morisawa et al. Studies on tuberculin active peptide I. The isolation, crystallization and properties of tuberculin active peptide from tubercle bacillus
Tangendjaja et al. Isolation of a mimosine degrading enzyme from leucaena leaf
Avadhani et al. Protein synthesis with isolated mitochondrial polysomes
Qureshi et al. The isolation of acyl carrier protein from the pigeon liver fatty acid synthetase complex II
Clark Alpha-1-protease inhibitor phenotypes in Australia
Igarashi et al. Growth-enhancing protein obtained from cell surface of cultured fibroblasts
EP0207165A4 (en) POLYPEPTIDE SECRETION VECTOR, MICROORGANISMS TRANSFORMED BY SAID VECTOR, AND PROCESS FOR THE PREPARATION OF POLYPEPTIDES WITH SAID MICROORGANISMS.
NO960710D0 (no) Nye tripeptider nyttige i immun- og CNS-terapi
Otterness et al. Effects of levamisole on the proliferation of thymic lymphocyte subpopulations
DK142380A (da) Fremgangsmaade til fremstilling af pentadecapeptider
ES439201A1 (es) Un procedimiento mejorado para preparar una vacuna por mediode un sistema de cultivo de celulas eucarioticas vivas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519